Photoactive fluorophores and methods of in vivo labeling

US11958976B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11958976-B2
Application numberUS-202217975310-A
CountryUS
Kind codeB2
Filing dateOct 27, 2022
Priority dateMay 20, 2016
Publication dateApr 16, 2024
Grant dateApr 16, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a photoactive fluorophore, a photoactive ligand, and a photoactive complex. The photoactive fluorophore includes a photoactivatable derivative of an azetidine-containing Janelia-Fluor dye. The photoactive ligand includes a photoactive fluorophore and a protein tag. The photoactive complex includes a photoactive ligand conjugated to a protein. Also provided are methods of in vivo labeling with and photoactivation of the photoactive fluorophore, ligand, and complex.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of the formula: wherein R is selected from the group consisting of a ligand that is a protein tag, and N-hydroxysuccinimide (NHS) ester. 2. A photoactive complex, comprising the compound according to claim 1 wherein R is the ligand, conjugated to a protein that binds the ligand. 3. The photoactive complex of claim 2 , wherein the compound is conjugated to the protein in vivo. 4. The compound of claim 1 , wherein the ligand is selected from the group consisting of: 5. The compound of claim 1 , of the formula: 6. The compound of claim 1 , of the formula: 7. The compound of claim 1 , of the formula:

Assignees

Inventors

Classifications

  • C09B11/24Primary

    Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title

  • Dibenzopyrans; Hydrogenated dibenzopyrans · CPC title

  • [b,f]-condensed · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • Nitrogen atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11958976B2 cover?
Provided are a photoactive fluorophore, a photoactive ligand, and a photoactive complex. The photoactive fluorophore includes a photoactivatable derivative of an azetidine-containing Janelia-Fluor dye. The photoactive ligand includes a photoactive fluorophore and a protein tag. The photoactive complex includes a photoactive ligand conjugated to a protein. Also provided are methods of in vivo la…
Who is the assignee on this patent?
Hughes Howard Med Inst
What technology area does this patent fall under?
Primary CPC classification C09B11/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).